Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for…
Specialty pharmacies must meet complex requirements, introducing administrative requirements that can be challenging for health systems to manage internally. Here some strategies that can be employed. The post How Health Systems Can Thrive in Navigating the Specialty Pharmacy Landscape appeared first on MedCity News.
The Indiana Biomedical Society (IBS) was recently recognized as TechNation’s Association of the Month for its commitment to supporting biomedical professionals across the state. Leading the organization is Naka Piohia, Crothall HTS Director at Marion General Hospital, who serves as IBS President. Founded in 1990, IBS provides a platform for professional development, networking, and industry…
Our mental health system is not designed to treat people in crisis. Instead of being administered right away and effectively, it shoves patients through a maze of barriers. If we are serious about saving lives, then we must reconsider how mental health care is administered. The post The Mental Health Crisis: Why Immediate and Affordable…
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins. The post How Are Hospitals Faring Financially in 2025? appeared first on MedCity News.
An expanded partnership with Humana will help Aledade’s FQHC and rural health clinic partners share savings in Medicare Advantage. The post Aledade, Humana Expand Value-Based Partnership to Support FQHCs and Rural Health Clinics appeared first on MedCity News.
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals’ Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare…
Creating adequate capacity for any therapeutic can be challenging, and the specialized technologies for manufacturing complex biologics require flexibility and agility in production processes. Here’s how contract development and manufacturing organizations (CDMOs) ensure that biopharmaceutical companies have a partner with the speed, flexibility, and expertise necessary for successful drug development and manufacturing. The post Evolving…
State, federal, and academic initiatives have poured time and resources into understanding and addressing these gaps. So why haven’t we made real, lasting progress? The post The Broken Approach to Health Disparities appeared first on MedCity News.
Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive population health analytics, customized physician results reporting and individualized patient engagement. The post Quest Diagnostics Strikes Generative AI Partnership with Google Cloud appeared first on MedCity News.